Literature DB >> 16199632

Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges.

Jodi S Dashe1, Brian M Casey, C Edward Wells, Donald D McIntire, E William Byrd, Kenneth J Leveno, F Gary Cunningham.   

Abstract

OBJECTIVE: To estimate a normal reference range for thyroid-stimulating hormone (TSH) at each point in gestation in singleton and twin pregnancies.
METHODS: All women enrolling for prenatal care from December 2000 through November 2001 underwent prospective TSH screening at their first visit. Separate nomograms were constructed for singleton and twin pregnancies using regression analysis. Values were converted to multiples of the median (MoM) for singleton pregnancies at each week of gestation.
RESULTS: Thyroid-stimulating hormone was evaluated in 13,599 singleton and 132 twin pregnancies. Thyroid-stimulating hormone decreased significantly during the first trimester, and the decrease was greater in twins (both P < .001). Had a nonpregnant reference (0.4-4.0 mU/L) been used rather than our nomogram, 28% of 342 singletons with TSH greater than 2 standard deviations above the mean would not have been identified. For singleton first-trimester pregnancies, the approximate upper limit of normal TSH was 4.0 MoM, and for twins, 3.5 MoM. Thereafter, the approximate upper limit was 2.5 MoM for singleton and twin pregnancies.
CONCLUSION: If thyroid testing is performed during pregnancy, nomograms that adjust for fetal number and gestational age may greatly improve disease detection. Values expressed as multiples of the median may facilitate comparisons across different laboratories and populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199632     DOI: 10.1097/01.AOG.0000175836.41390.73

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  38 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

Review 2.  Serum TSH determinations in pregnancy: how, when and why?

Authors:  Daniel Glinoer; Carole A Spencer
Journal:  Nat Rev Endocrinol       Date:  2010-06-08       Impact factor: 43.330

3.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

4.  Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.

Authors:  E Papini; R Negro; A Pinchera; R Guglielmi; A Baroli; P Beck-Peccoz; P Garofalo; M P Pisoni; M Zini; R Elisei; L Chiovato
Journal:  J Endocrinol Invest       Date:  2010-07-13       Impact factor: 4.256

Review 5.  Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals.

Authors:  Offie P Soldin
Journal:  Ther Drug Monit       Date:  2006-02       Impact factor: 3.681

6.  Iodine in pregnancy: is salt iodization enough?

Authors:  Elizabeth N Pearce
Journal:  J Clin Endocrinol Metab       Date:  2008-07       Impact factor: 5.958

Review 7.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

8.  High prevalence of thyroid dysfunction in pregnant women.

Authors:  M Altomare; S La Vignera; P Asero; D Recupero; R A Condorelli; P Scollo; A Gulisano; E Magro; D Tumino; S Tumino; E Vicari; V Leanza; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2012-10-22       Impact factor: 4.256

9.  Effect of thyroid peroxidase antibodies on thyroid-stimulating hormone reference limits in a primarily Latina population.

Authors:  Richard H Lee; Carole A Spencer; Martin N Montoro; Paola Aghajanian; T Murphy Goodwin; Erin A Miller; Ivana Petrovic; Lewis E Braverman; Jorge H Mestman
Journal:  Obstet Med       Date:  2009-11-30

Review 10.  Autoimmune thyroid disease in pregnancy: a review.

Authors:  Juan C Galofre; Terry F Davies
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.